Inactive Instrument

Other languages PharmaCyte Biotech, Inc. Other OTC

Equities

PMCB

US71715X1046

Other languages

Unlock all the news: Be the first to know and act before the market!

PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	19/03
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	16/12
PharmaCyte Biotech, Inc. Provides Corporate Update on Cell-In-A-Box Technology	31/23/31
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	18/23/18
PharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	01/23/01
PharmaCyte Biotech, Inc. announces an Equity Buyback for 7,750,000 shares, for $25.19 million.	11/23/11
PharmaCyte Biotech, Inc authorizes a Buyback Plan.	11/23/11
PharmaCyte Biotech, Inc. announces an Equity Buyback for $10 million worth of its shares.	02/23/02
PharmaCyte Biotech, Inc. authorizes a Buyback Plan.	31/23/31
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	15/22/15
PharmaCyte Biotech, Inc. Announces Resignation of Jack E. Stover as Director	08/22/08
PharmaCyte Biotech, Inc. Announces Resignation of Gerald W. Crabtree as Chief Scientific Officer	15/22/15
PharmaCyte Biotech, Inc. Announces Management Changes	08/22/08
PharmaCyte Biotech CEO Kenneth Waggoner Resigns; Board Forms Business Review Committee; Shares Rise	07/22/07
PharmaCyte Biotech, Inc. Announces Management Changes	07/22/07
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	15/22/15
PharmaCyte Biotech Reaches Agreement With Iroquois to Appoint Two Directors to Board	15/22/15
PharmaCyte Biotech, Inc. Announces Board Appointments	15/22/15
PharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2022	29/22/29
PharmaCyte Biotech Issues a Statement in Response to Iroquois Capital’s Preliminary Consent Statement	28/22/28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages PharmaCyte Biotech, Inc. Other OTC

Equities

PMCB

US71715X1046

Other languages

Filters